Medtech Insight is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA OKs Ophtec's capsular tension ring:

This article was originally published in Clinica

Executive Summary

The US FDA has approved for sale Ophtec USA's capsular tension ring (CTR) for stabilising the eye's capsular bag during cataract surgery involving the implantation of an intraocular lens (IOL). The StabilEyes CTR provides secondary capsular bag support, which is helpful when the integrity of the patient's capsular bag is, or might become, compromised during IOL implantation. The device will be sold in the US, Canada and Mexico by Advanced Medical Optics. Ophtec USA, a subsidiary of Groningen, the Netherlands-based Ophtec, has been manufacturing CTRs under the Oculaid brand outside of North America for over 10 years.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT058852

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel